Correlation Between Dianthus Therapeutics and Zenas BioPharma,

Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dianthus Therapeutics and Zenas BioPharma, Common, you can compare the effects of market volatilities on Dianthus Therapeutics and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Zenas BioPharma,.

Diversification Opportunities for Dianthus Therapeutics and Zenas BioPharma,

0.41

Correlation Coefficient

Dianthus Therapeutics  Zenas BioPharma,

Very weak diversification

The 3 months correlation between Dianthus and Zenas is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Zenas BioPharma, go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Zenas BioPharma,

Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Zenas BioPharma,. But the stock apears to be less risky and, when comparing its historical volatility, Dianthus Therapeutics is 1.27 times less risky than Zenas BioPharma,. The stock trades about -0.02 of its potential returns per unit of risk. The Zenas BioPharma, Common is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  957.00  in Zenas BioPharma, Common on December 21, 2024 and sell it today you would lose (105.00) from holding Zenas BioPharma, Common or give up 10.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Dianthus Therapeutics  vs.  Zenas BioPharma, Common

Dianthus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Zenas BioPharma, Common

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zenas BioPharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Zenas BioPharma, is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Dianthus Therapeutics and Zenas BioPharma,

The main advantage of trading using opposite Dianthus Therapeutics and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.

The idea behind Dianthus Therapeutics and Zenas BioPharma, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.